 |
2015-12-22 21:03:53 Is this a ●●●●●●ary or ●●●●●●ent ●●●●●●on? :.●●●●●●●●●●●●ive.●●●●●●-●●●●●●-loss-pills-●●●●●● ●●●●●●ction alli ●●●●●● loss ●●●●●● 2014 ●●●●●●al about A ●●●●●● ●●●●●●es C●●●●●●n Inc, now owned by Teva. In 2008, the FTC ●●●●●●d C●●●●●●n of ●●●●●● ●●●●●●●●●●●●s to not sell a ●●●●●●c ●●●●●●n of its ●●●●●●lness drugP●●●●●●l. That case was put on hold ●●●●●●g the S●●●●●● C●●●●●●●●●●●●. :.●●●●●●●●●●●●●●●●●●dex.●●●●●●hene-●●●●●●e-●●●●●●-●●●●●● ●●●●●●arent can a ●●●●●● ●●●●●● ●●●●●●ibe ●●●●●● range ●●●●●●al F●●●●●●ntals for ●●●●●●ities vary on an ●●●●●●dual basis. The ●●●●●● & ●●●●●● ●●●●●●x on ●●●●●●e has been hit by ●●●●●●icant price ●●●●●●ss ●●●●●●ly, ●●●●●● by the ●●●●●●ation of a ●●●●●●wn in ●●●●●●ng ●●●●●● ●●●●●● (in ●●●●●●ular, China's ●●●●●●ted ●●●●●●), ●●●●●●ed ●●●●●● and ●●●●●●ss in ●●●●●●ped ●●●●●● ●●●●●●. As of the end of June, this had ●●●●●●ed in a year-over-year ●●●●●●e of 12.5% ●●●●●● a ●●●●●● of ●●●●●●, with ●●●●●●t ●●●●●●g well below its three and five year ●●●●●●es at -20.2% and -13.4%, ●●●●●●●●●●●●. |